The NF-kB Target, Gadd45Beta, in Lymphocytes and Liver
The NF-kB Target, Gadd45Beta, in Lymphocytes and Liver
批准号:
7337137
负责人:
GUIDO FRANZOSO
金额:
$21.76万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-01-01 至 2011-12-31
关键词:
AblationAddressAntigensApoptosisApoptoticAutoimmunityBiological AssayCD4 Positive T LymphocytesCell DeathCell SurvivalCell physiologyCellsCessation of lifeChronicClassificationCytokine ReceptorsDefectDendritic CellsGrowthHepaticHepatocyteHomeostasisImmuneImmune responseImmunityIn VitroInflammationInflammatory ResponseInjuryJNK-activating protein kinaseKineticsKnockout MiceLinkLiverLiver RegenerationLymphocyteLymphocyte FunctionLymphopoiesisMAP Kinase GeneMAPK8 geneMalignant NeoplasmsMarshalMediatingMediator of activation proteinMemoryModelingMonitorNF-kappa BNatural regenerationPartial HepatectomyPathway interactionsPeptidesPeripheralPhysiologicalPrincipal InvestigatorProcessReceptor SignalingRegulationRoleSignal TransductionSurveysSystemT memory cellT-Cell ActivationT-Cell DevelopmentT-LymphocyteTestingToxic effectTransducersUp-RegulationWild Type Mouseattenuationbasein vivoinsightkillingsnovel therapeuticsprogramsreceptorreconstitutionresponseresponse to injurytooltumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In addition to marshalling immune and inflammatory responses, NF-kappaB controls cell survival. This control is crucial to B lymphopoiesis, T cell homeostasis, oncogenesis, and to antagonize TNFalpha-induced killing. With regard to TNFalpha the NF-kappaB anti-apoptotic activity involves the suppression of JNK signaling. Using an unbiased screen, we have identified Gadd45beta/Myd118 as a pivotal mediator of this suppression, and have found that its activity depends on direct blockade of the JNK kinase, MKK7/JNKK2. Gadd45beta is required for CD4+ T cell responses and hepato-protection from external challenge - two processes controlled in part by JNK and NF-kappaB. However, the mechanism(s) by which Gadd45beta regulates T lymphocyte function and the relevance of this regulation to adaptive immunity, in vivo, are not known. Likewise, the precise role of Gadd45beta in the liver response to injury remain to be determined. This proposal has three Specific Aims, which will address these issues concurrently. In Aim 1, by using an in vivo approach, we will determine the physiologic function of Gadd45beta, and its control of MAPK signaling, in T cell homeostasis and adaptive immune responses. We will begin by examining kinetics of expansion and contraction of the Gadd45beta-/- T cell pool during a physiologic response to antigen. The relevance of the Gadd45beta anti-apoptotic activity to peripheral T cell deletion and memory T cell development will be established using well-characterized models. In Aim 2, we will assess the basis for the Gadd45beta control of T cell function, during physiologic antigen-priming, ex vivo. Using this system, we will establish the precise effects of Gadd45beta ablation on T cell activation, proliferation, TH1/TH2 differentiation, and AICD. The impact of Gadd45beta on TCR-induced MAPK pathways and its consequences on T cell function will be specifically examined. In Aim 3, we will determine the bases for the role of Gadd45beta in the liver response to injury, using well-established models of TNFalpha-induced, JNK-mediated hepato-toxicity. In particular, we will establish the relevance of the Gadd45beta control of JNK signaling to the NF-kappaB protective function in the liver. Hepatocyte function will be also studied in vitro, in the absence of any stromal or organismal influences. Altogether, these studies may provide important new insights into mechanisms of autoimmunity, chronic inflammation, and cancer, and perhaps, new therapeutic tools for their treatments.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
In the Crosshairs: NF-κB Targets the JNK Signaling Cascade.
十字准线中:NF-κB 以 JNK 信号级联为目标。
DOI:
10.2174/156801405774933188
发表时间:
2005
期刊:
Current medicinal chemistry. Anti-inflammatory & anti-allergy agents
影响因子:
--
作者:
[Pham,CanG, Papa,Salvatore, Bubici,Concetta, Zazzeroni,Francesca, Franzoso,Guido]
通讯作者:
Franzoso,Guido
DOI:
10.1158/0008-5472.can-17-1833
发表时间:
2018-03-01
期刊:
Cancer research
影响因子:
11.2
作者:
[Verzella D, Bennett J, Fischietti M, Thotakura AK, Recordati C, Pasqualini F, Capece D, Vecchiotti D, D'Andrea D, Di Francesco B, De Maglie M, Begalli F, Tornatore L, Papa S, Lawrence T, Forbes SJ, Sica A, Alesse E, Zazzeroni F, Franzoso G]
通讯作者:
Franzoso G
DOI:
10.1515/bc.2009.111
发表时间:
2009-10
期刊:
Biological chemistry
影响因子:
3.7
作者:
[Papa S, Bubici C, Zazzeroni F, Franzoso G]
通讯作者:
Franzoso G
DOI:
10.1016/j.ccr.2014.07.027
发表时间:
2014-10-13
期刊:
Cancer cell
影响因子:
50.3
作者:
[Tornatore L, Sandomenico A, Raimondo D, Low C, Rocci A, Tralau-Stewart C, Capece D, D'Andrea D, Bua M, Boyle E, van Duin M, Zoppoli P, Jaxa-Chamiec A, Thotakura AK, Dyson J, Walker BA, Leonardi A, Chambery A, Driessen C, Sonneveld P, Morgan G, Palumbo A, Tramontano A, Rahemtulla A, Ruvo M, Franzoso G]
通讯作者:
Franzoso G
DOI:
10.1038/ncb2324
发表时间:
2011-08-28
期刊:
Nature cell biology
影响因子:
21.3
作者:
[]
通讯作者:
共 8 条
Gadd45beta in JNK Signaling, Apoptosis, and Cancer
-
批准号:6560603
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2003
-
负责人:GUIDO FRANZOSO
-
依托单位:
Gadd45beta in JNK Signaling, Apoptosis, and Cancer
-
批准号:7058780
-
项目类别:
-
资助金额:$29.82万
-
财政年份:2003
-
负责人:GUIDO FRANZOSO
-
依托单位:
Gadd45beta in JNK Signaling, Apoptosis, and Cancer
-
批准号:6892198
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2003
-
负责人:GUIDO FRANZOSO
-
依托单位:
Gadd45beta in JNK Signaling, Apoptosis, and Cancer
-
批准号:7227556
-
项目类别:
-
资助金额:$13.59万
-
财政年份:2003
-
负责人:GUIDO FRANZOSO
-
依托单位:
Gadd45beta in JNK Signaling, Apoptosis, and Cancer
-
批准号:7501617
-
项目类别:
-
资助金额:$15.37万
-
财政年份:2003
-
负责人:GUIDO FRANZOSO
-
依托单位:
Gadd45beta in JNK Signaling, Apoptosis, and Cancer
-
批准号:6747921
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2003
-
负责人:GUIDO FRANZOSO
-
依托单位:
NF-KB REGULATION OF LYMPHOCYTE FUNCTION AND APOPTOSIS
-
批准号:6626726
-
项目类别:
-
资助金额:$26.28万
-
财政年份:2000
-
负责人:GUIDO FRANZOSO
-
依托单位:
The NF-kB Target, Gadd45Beta, in Lymphocytes and Liver
-
批准号:7161748
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2000
-
负责人:GUIDO FRANZOSO
-
依托单位:
NF-KB REGULATION OF LYMPHOCYTE FUNCTION AND APOPTOSIS
-
批准号:6689573
-
项目类别:
-
资助金额:$27.07万
-
财政年份:2000
-
负责人:GUIDO FRANZOSO
-
依托单位:
NF-KB REGULATION OF LYMPHOCYTE FUNCTION AND APOPTOSIS
-
批准号:6489336
-
项目类别:
-
资助金额:$25.52万
-
财政年份:2000
-
负责人:GUIDO FRANZOSO
-
依托单位:
NF-KB REGULATION OF LYMPHOCYTE FUNCTION AND APOPTOSIS
-
批准号:6032874
-
项目类别:
-
资助金额:$21.72万
-
财政年份:2000
-
负责人:GUIDO FRANZOSO
-
依托单位:
NF-KB REGULATION OF LYMPHOCYTE FUNCTION AND APOPTOSIS
-
批准号:6342198
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2000
-
负责人:GUIDO FRANZOSO
-
依托单位:
The NF-kB Target, Gadd45Beta, in Lymphocytes and Liver
-
批准号:7522699
-
项目类别:
-
资助金额:$21.76万
-
财政年份:2000
-
负责人:GUIDO FRANZOSO
-
依托单位:
The NF-kB Target, Gadd45Beta, in Lymphocytes and Liver
-
批准号:6873422
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2000
-
负责人:GUIDO FRANZOSO
-
依托单位:
The NF-kB Target, Gadd45Beta, in Lymphocytes and Liver
-
批准号:7007697
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2000
-
负责人:GUIDO FRANZOSO
-
依托单位:
海外基金